openPR Logo
Press release

Strategies for Stakeholders: Navigating the US$15.6 Billion Cell Therapy Manufacturing Market by 2033 | Insights by FMI Inc.

09-06-2023 03:47 PM CET | Health & Medicine

Press release from: Future Market Insights Inc.

Cell Therapy Manufacturing Market

Cell Therapy Manufacturing Market

Anticipated to attain a valuation of approximately US$ 4,134.48 million in 2023, the global market for Cell Therapy Manufacturing is on a trajectory of substantial growth. This expansion is projected to continue at a Compound Annual Growth Rate (CAGR) of 14.2% spanning from 2023 to 2033. By the culmination of 2033, it is expected that the market will surge to an estimated valuation of around US$ 15,634.67 million. Notably, autologous cell therapy manufacturing spearheads the global market, boasting a significant share of about 56.0% as of 2021.

Cell therapies are utilized widely to treat viral infections, cancer, hemoglobinopathies, and hereditary immunological disorders. The introduction of reagents and closed-system automated equipment for the manufacturing of cellular therapies is an outcome of the increasing research activities in the field of such therapies.

A decentralized manufacturing model for clinical trials in cell therapies engaging multiple sites is being favored across the globe. Such instances advocate the treatment of patients using cells, which are produced by utilizing automated equipment at each participating center by considering a single, centrally held investigational new drug application (IND).

Explore the Booming Cell Therapy Manufacturing Market with Our Sample Report! @
https://www.futuremarketinsights.com/reports/sample/rep-gb-15536

Many academic centres are nowadays investing in the development of such automated devices for point-of-care manufacturing and engagement in decentralized multi--center Clinical Trials. The global cell therapy manufacturing market would thus observe a boom in the next decade. Besides, the introduction of novel therapies licensed by regulatory bodies for targeted therapeutic approach would further propel the overall growth in the market during the projected period.

Key Takeaways from Market Study

-By source, the autologous segment held a global market share of about 0% in 2021.
-Based on indication, the cancer segment held nearly 0% in 2021 in the cell therapy manufacturing market.
-In terms of purpose, the clinical segment accounted for around 0% of the global market share in 2021.
-Injectable route of administration of cell therapies generated a global market share of around 0% in 2021.
-By cell type, the hematopoietic stem cells (HSC) segment held a share of around 0% in the global cell therapy manufacturing market in 2021.
-By end use, the hospital settings category generated a share of around 1% in 2021 in the global cell therapy manufacturing market.
-China held a share of around 2% in 2021 in the East Asia cell therapy manufacturing market.

"Increasing number of research activities by key companies to reduce risks and get ready for a highly productive future are anticipated to drive the market. Besides, they are striving to develop innovative technologies that can assist investigators in automating their processes for gaining success in the future," says an analyst of Future Market Insights.

Competitive Landscape: Cell Therapy Manufacturing Market

Key players in the cell therapy manufacturing market are focusing on R&D activities to initiate regenerative medicine manufacturing. Moreover, they are promoting commercial manufacturing for their clients by offering novel solutions to cell therapy developers.

For instance,

-In March 2022, Thermo Fisher Scientific presented a new large-volume electroporation system, the purpose of which is to simplify cell therapy development. The company aims to simplify transition from clinical development to commercial manufacturing among Cell Therapy Developers.
-Charles River Laboratories' Memphis plant became the first CDMO in North America to manufacture commercial allogeneic cell therapies after receiving European Medicines Agency (EMA) approval in August 2022.

Get Exclusive Insights on Cell Therapy Manufacturing Market

Future Market Insights offers a unique perspective and actionable insights on the cell therapy manufacturing market in its latest study, presenting a historical demand assessment of 2012 - 2021 and projections for 2022 - 2032. The global cell therapy manufacturing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Key Players:

-Merck KGaA
-Avantor, Inc.
-Cell Therapies Pty Ltd
-Thermo Fisher Scientific
-Charles River Laboratories
-Catalent, Inc
-Bio-Techne
vCytiva
-Lonza
-The Discovery Labs
-BIOCENTRIQ
-FUJIFILM Diosynth Biotechnologies
-Novartis AG
-Bristol-Myers Squibb Company
-Gilead Sciences, Inc.
-WuXi AppTec.
-OXGENE
-Pharmaron
-Aldevron
-FLODESIGN SONICS
-Exothera

Get Ahead with Comprehensive Information - Purchase The Report Today!
https://www.futuremarketinsights.com/checkout/15536

Key Segments Covered in Cell Therapy Manufacturing Industry

By Source:

-Autologous
-Allogenic

By Indication:

-HIV
-Autoimmune Disorders
-Immune Deficiencies
-Cancer
-Neurological Disorders

By Manufacturing Purpose:

-Clinical
-Commercial
-Pre-clinical

By Route of Administration:

-Topical
-Injectable
-Infusion
-Implantable Bio-Scaffold

By Cell Type:

-Hematopoietic (Blood-Forming) Stem Cells (HSC)
-Skeletal Muscle Stem Cells
-Mesenchymal Stem Cells
-Lymphocytes
-Dendritic Cells
-Pancreatic Islet Cells
-CAR-T Cells

By End User:

-Hospital Settings
-Intensive Outpatient Treatment Centers
-Academic and Research Institutes
-Specialty Clinics

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Read the Complete Analysis Here: 
https://www.futuremarketinsights.com/reports/cell-therapy-manufacturing-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Strategies for Stakeholders: Navigating the US$15.6 Billion Cell Therapy Manufacturing Market by 2033 | Insights by FMI Inc. here

News-ID: 3198675 • Views:

More Releases from Future Market Insights Inc.

Global Inherited Orphan Blood Disorders Therapeutics Market to Grow at 9.0% CAGR from 2025 to 2035, Reaching USD 4.2 Billion by 2035.
Global Inherited Orphan Blood Disorders Therapeutics Market to Grow at 9.0% CAGR …
The global market for Inherited Orphan Blood Disorders Therapeutics is poised for substantial growth over the next decade, with projections estimating the market to expand from USD 1.8 billion in 2025 to USD 4.2 billion by 2035. This represents a compound annual growth rate (CAGR) of 9.0%, reflecting the increasing need for targeted therapeutic solutions for rare genetic blood disorders. Inherited orphan blood disorders, such as sickle cell anemia, thalassemia, and
The Cardiovascular Surgical Devices Market: A Key Focus on Growth and Innovation in Cardiac Healthcare
The Cardiovascular Surgical Devices Market: A Key Focus on Growth and Innovation …
The cardiovascular surgical devices market is undergoing a dynamic transformation, offering significant opportunities for healthcare providers, medical device manufacturers, and patients alike. With an estimated market value of USD 57.9 billion in 2025, the sector is projected to experience robust growth, reaching USD 122.7 billion by 2035. This impressive expansion, at a compound annual growth rate (CAGR) of 7.8%, is propelled by a convergence of factors including the rising incidence
Surgical Heart Valves Market Poised for Unprecedented Growth, Projected to Reach USD 36.6 Billion by 2035
Surgical Heart Valves Market Poised for Unprecedented Growth, Projected to Reach …
The surgical heart valves market is entering a new era of expansion, projected to grow from USD 8,897.2 million in 2025 to a staggering USD 36,625.0 million by 2035. With a remarkable compound annual growth rate (CAGR) of 15.2% during the forecast period, the sector is set to be one of the fastest-growing segments within the global cardiovascular medical devices industry. As the world grapples with rising cardiovascular disease rates
Paediatric Oncology Therapeutics Market Set for Robust Growth, Projected to Reach USD 6.3 Billion by 2035
Paediatric Oncology Therapeutics Market Set for Robust Growth, Projected to Reac …
The global paediatric oncology therapeutics market is poised for significant growth, with a projected compound annual growth rate (CAGR) of 8.0%, reaching a market value of USD 6.3 billion by 2035, up from USD 2.9 billion in 2025. This surge is driven by the increasing prevalence of childhood cancers and the escalating demand for advanced, age-specific treatment options. As the global incidence of paediatric cancers rises, the need for effective, safe,

All 5 Releases


More Releases for Cell

Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY